Turin, May 20, 2026.
ELITechGroup – A Bruker Company has officially inaugurated the OEC – Operations Excellence Center in Turin, the new manufacturing and logistics hub dedicated to molecular diagnostics.
At the ribbon-cutting ceremony, from left to right: Pierangelo Clerici, President of the Italian Association of Clinical Microbiologists; Roberto Meda, Senior Vice President of Bruker MDx; Eleonora Faina, Deputy Director General of Unione Industriali Torino; Andrea Tronzano, Productivity Assessor for the Piedmont Region.
The opening of the OEC marks a major milestone in the company’s growth journey and long-term investment strategy, further reinforcing ELITechGroup’s industrial and operational capabilities while supporting its continued global expansion and commitment to innovation.
With the addition of the OEC, the company now exceeds 8,000 square meters dedicated to research, production, logistics, strategic functions, and commercial operations, consolidating its role among the leading European hubs for molecular biology.
The OEC integrates with the company’s existing infrastructure, including the headquarters inaugurated in December 2022, and reflects ELITechGroup’s ongoing commitment to advanced technologies and operational excellence.
“This new facility represents a strategic investment in our industrial capabilities and in the future of molecular diagnostics,” said Roberto Meda, Senior Vice President Bruker MDx. “The OEC introduces a highly automated production model that significantly expands the scale and efficiency of our operations. By leveraging fully automated production lines, we can ensure standardized, scalable, and high-quality processes, further strengthening our ability to innovate and support clinical laboratories worldwide.”
The inauguration follows the recent launch of MYGenius PRO, the latest solution in the company’s molecular diagnostics portfolio, further underscoring its commitment to advancing solutions in infectious disease diagnostics.
About Us
ELITechGroup is part of Bruker Corporation and contributes to the Bruker Microbiology & Infection Diagnostics (BMID) division, developing cutting-edge technologies to support the evolving needs of clinical laboratories globally.